What was most notable, was that the liver mRNA expression of CD5L was significantly increased in the diseased NAFLD group as a whole (n = 21), relative to the normal liver group (n = 13) (6.945 ± 0.722 versus1.68 ± 0.269; p = 0.000). Here, CD5L is linked to metabolic dysfunction-associated steatotic liver disease.